Phase 2 Study With Abraxane (Nab®Paclitaxel) in Metastatic Colorectal Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

May 5, 2014

Primary Completion Date

November 10, 2014

Study Completion Date

January 9, 2015

Conditions
Colorectal Neoplasms
Interventions
DRUG

ABI-007

Trial Locations (6)

34298

Centre Regional de Lutte contre le Cancer Val d'Aurelle, Montpellier

44805

CRLCC Centre Rene Gauducheau, Saint-Herblain

54511

Centre Alexis Vautrin, Vandœuvre-lès-Nancy

59020

Centre Oscar Lambret, Dept. de Cancerologie Digestive et Urologique, Lille

92210

Institut Curie, Saint-Cloud

94805

Institut Gustave Roussy Hematologie, Villejuif

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Celgene

INDUSTRY